Ab175993
antibody from Aladdin Scientific
Targeting: CXCR4
CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- Ab175993 - Provider product page
- Provider
- Aladdin Scientific
- Product name
- Ulocuplumab (anti-CXCR4)
- Antibody type
- Recombinant
- Description
- Ulocuplumab (anti-CXCR4) is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab (anti-CXCR4) induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab (anti-CXCR4) exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
- Reactivity
- Human, Mouse
- Conjugate
- Unconjugated
- Vial size
- 100_g,10mg,1mg,5mg
- Concentration
- Lot by Lot
- Storage
- Store at -80_ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
No comments: Submit comment
Supportive validation
- Submitted by
- Aladdin Scientific (provider)
- Main image
- Experimental details
- Ulocuplumab (anti-CXCR4) (Ab175993) - Flow Cytometry Flow Cytometry analysis of Jurkat cells labelling CXCR4 (red) with Ulocuplumab (anti-CXCR4) (Ab175993). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.